Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
VESTIGE Trial Results: Dupilumab in Type 2 Asthma

VESTIGE Trial Results: Dupilumab in Type 2 Asthma

This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

Loss of Smell Improvement in Patients With CRSwNP

Loss of Smell Improvement in Patients With CRSwNP

Infectious Disease During Mass Gathering

Infectious Disease During Mass Gathering

Type 2 Inflammation in the Pathophysiology of the Lower Airways

Type 2 Inflammation in the Pathophysiology of the Lower Airways

Beyond High-Risk: Expanding RSV Protection for Newborns and Infants

Beyond High-Risk: Expanding RSV Protection for Newborns and Infants

VESTIGE study

VESTIGE study

Mucus Plugging Is a Key Component of Remodeling<br /> in Asthma, Leading to Fixed Airway Obstruction

Mucus Plugging Is a Key Component of Remodeling
in Asthma, Leading to Fixed Airway Obstruction

Loss of Smell Is a Key Symptom in CRSwNP

Loss of Smell Is a Key Symptom in CRSwNP

Every Moment Matters: Navigating Diagnosis of Fabry Disease

Every Moment Matters: Navigating Diagnosis of Fabry Disease

FeNO Is a Clinically Useful Biomarker of Type 2 Inflammation in Pediatric Patients With Asthma

Pediatric Asthma FeNO

RSV Burden in Jazan

RSV Burden in Jazan